Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Acta Crystallographica Section D: Biological Crystallography

• Publication date

  2014-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1107/S1399004713033221PMID 24598749PMCID PMC3949514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• REFMAC5 for the refinement of macromolecular crystal structures

  2011cited by this paper
• Overview of the CCP4 suite and current developments

  2011cited by this paper
• Features and development of Coot

  2010cited by this paper
• Binding of nitrogen‐containing bisphosphonates (N‐BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer

  2010cited by this paper
• Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs

  2006cited by this paper
• Farnesyl Diphosphate Synthase Is a Cytosolic Enzyme in Leishmania major Promastigotes and Its Overexpression Confers Resistance to Risedronate

  2006cited by this paper
• The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

  2006cited by this paper
• Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines.

  2006cited by this paper
• Farnesyl diphosphate synthase; regulation of product specificity.

  2005cited by this paper
• Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.

  2005cited by this paper
• Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: Implications for drug design

  2005cited by this paper
• research papers Acta Crystallographica Section D Biological

  2003cited by this paper
• Farnesyl Pyrophosphate Synthase Is an Essential Enzyme in Trypanosoma brucei

  2003cited by this paper
• Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate.

  2002cited by this paper
• Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

  2001cited by this paper
• Therapeutic approaches to bone diseases.

  2000cited by this paper
• Protein design of geranyl diphosphate synthase. Structural features that define the product specificities of prenyltransferases.

  1999cited by this paper
• Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis

  1999cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• A Role of the Amino Acid Residue Located on the Fifth Position before the First Aspartate-rich Motif of Farnesyl Diphosphate Synthase on Determination of the Final Product*

  1996cited by this paper
• Errors in protein structures

  1996cited by this paper
• Verification of protein structures : Side-chain planarity

  1996cited by this paper
• Regulation of product chain length by isoprenyl diphosphate synthases.

  1996influential reference
• Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-A resolution.

  1994cited by this paper
• AMoRe: an automated package for molecular replacement

  1994cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991influential reference
• Sparse matrix sampling: a screening method for crystallization of proteins

  1991influential reference
• Prenyltransferase; determination of the binding mechanism and individual kinetic constants for farnesylpyrophosphate synthetase by rapid quench and isotope partitioning experiments.

  1981cited by this paper
• The interpretation of protein structures: estimation of static accessibility.

  1971cited by this paper

• Silver-N-Heterocyclic Complexes Against Leishmania major: In Vitro, In Vivo and In Silico Therapeutic Activities

  2026cites this paper
• Structural insights into the molecular mechanisms of OsFBN5-induced OsSPS3 catalysis

  2026cites this paper
• Tetranuclear and dinuclear Cu(II) complexes with risedronate as anti-Trypanosoma cruzi and anti-Leishmania mexicana agents. Synthesis, crystal structures, and biological evaluation.

  2025cites this paper
• Protozoan Neglected Tropical Diseases (NTDs) Target Inhibition of Alkaloids from Croton linearis Jacq Leaves: A Molecular Docking and ADMET Approach

  2025cites this paper
• Molecular docking and simulation analysis of selected herbal compounds against GP63, FPPS, and NMT, three important Leishmania major proteins

  2025cites this paper
• Inhibitors of Farnesyl Diphosphate Synthase and Squalene Synthase: Potential Source for Anti-Trypanosomatidae Drug Discovery

  2023cites this paper
• In vitro and in vivo antileishmanial activity of the hanging sedge flavonoids based on bio‐ guided fractionation assay

  2023cites this paper
• In silico identification of potential phytochemical inhibitors targeting farnesyl diphosphate synthase of cotton bollworm (Helicoverpa armigera)

  2022cites this paper
• Phosphonate and Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthases: A Structure-Guided Perspective

  2021cites this paper
• Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.

  2021cites this paper
• Identification of potential antileishmanial agents via structure-based molecular simulations.

  2021cites this paper
• Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis

  2021influential citation
• Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs

  2020cites this paper
• Identifying structural determinants of product specificity in Leishmania major farnesyl diphosphate synthase.

  2020cites this paper
• Insights about the structure of farnesyl diphosphate synthase (FPPS) and the activity of bisphosphonates on the proliferation and ultrastructure of Leishmania and Giardia

  2020cites this paper
• Design of Potential Anti-Leishmanial Pharmacophores via In Silico Drug Repurposing

  2020cites this paper
• Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

  2019cites this paper
• Leishmania Proteomics: An in Silico Perspective

  2019cites this paper
• Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors

  2018cites this paper
• Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.

  2017cites this paper
• Effects of an Encapsulated Fruit and Vegetable Juice Concentrate on Obesity-Induced Systemic Inflammation: A Randomised Controlled Trial

  2017cites this paper
• Two Eucommia farnesyl diphosphate synthases exhibit distinct enzymatic properties leading to end product preferences.

  2017cites this paper
• Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase

  2016cites this paper
• Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries.

  2016cites this paper
• Ursolic Acid, a Natural Pentacylcic Triterpene from Ochrosia elliptica and Its Role in The Management of Certain Neglected Tropical Diseases

  2016cites this paper
• The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases—Part III: In-Silico Molecular Docking Investigations

  2016cites this paper
• Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase from Pseudomonas aeruginosa

  2015cites this paper
• Sterol Biosynthesis Pathway as an Alternative for the Anti-Protozoan Parasite Chemotherapy.

  2015cites this paper
• In silico investigation of the anti-leishmanial role of algae and corals active substances using molecular dynamic simulation and Molecular docking methods

  year unknowncites this paper